Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88LF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,333
Award facts
- Contract value 100% obligated
- $35,333.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,333.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pens on January 9, 2026, with completion targeted for January 12, 2026. This non-set-aside award represents a specific task order fulfilled through the company's parent organization Cencora, Inc.'s primary indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, supporting the DLA's medical supply chain operations.
Dupixent is a biologic medication indicated for treating atopic dermatitis, eosinophilic esophagitis, and certain asthma conditions, reflecting the comprehensive pharmaceutical procurement requirements of federal military healthcare systems. This delivery order exemplifies the routine execution of task orders under Cencora's global pharmaceutical supply vehicle, which enables the company to distribute brand-name drugs, generic medications, specialty therapeutics, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and military treatment facilities worldwide. The award demonstrates AmerisourceBergen's continued role as a critical vendor within the federal medical supply chain for defense-related healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F88LF?
SPE2DR26F88LF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F88LF worth?
The government has obligated $35,333 on SPE2DR26F88LF.
Is contract SPE2DR26F88LF an order under another contract?
Yes. SPE2DR26F88LF is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88LF competed?
The extent of competition for SPE2DR26F88LF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award